VanEck Biotech ETF
BBH
BBH
109 hedge funds and large institutions have $132M invested in VanEck Biotech ETF in 2022 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 14 increasing their positions, 39 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
64% less repeat investments, than reductions
Existing positions increased: 14 | Existing positions reduced: 39
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $233K
Holders
109
Holding in Top 10
–
Calls
–
Puts
$233K
Top Buyers
| 1 | +$11.3M | |
| 2 | +$1.05M | |
| 3 | +$971K | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$903K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$678K |
Top Sellers
| 1 | -$2.63M | |
| 2 | -$2.63M | |
| 3 | -$1.31M | |
| 4 |
WANY
Wealthspire Advisors (New York)
New York
|
-$1.16M |
| 5 |
Commonwealth Equity Services
Waltham,
Massachusetts
|
-$952K |